Concord Drugs Ltd — Board Meeting, 03-07-2025: Board Meeting

Concord Drugs Limited has announced a board meeting on which it approved increasing its authorised share capital from Rs. 11 Cr to Rs. 15.5 Cr, subject to shareholder approval at the upcoming EGM. The company plans a preferential issue of up to 31.75 lakh equity shares at Rs. 36.30 each, totaling Rs. 11.53 Cr, to non-promoter investors. Additionally, it will issue up to 20.25 lakh warrants convertible into equity shares at the same price, aggregating Rs. 7.35 Cr, to both promoter and non-promoter categories. No change in control is expected post-issuance. The EGM notice and scrutinizer appointment were also approved.